References
- Aanouz, I., Belhassan, A., El-Khatabi, K., Lakhlifi, T., El-Ldrissi, M., Bouachrine, M. (2020). Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations. Journal of Biomolecular Structure and Design, 6, 1–9. https://doi.org/https://doi.org/10.1080/07391102.2020.1758790.
- Alex, Z. (2020). Potential non-covalent SARS-CoV-2 3C-like protease inhibitors designed using generative deep learning approaches and reviewed by human medicinal chemist in virtual reality. ChemRxiv preprint. https://doi.org/https://doi.org/10.26434/chemrxiv.12301457.v1
- Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/https://doi.org/10.1063/1.448118
- Bosch, B. J., van der Zee, R., de Haan, C. A. M., & Rottier, P. J. M. (2003). The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. Journal of Virology, 77(16), 8801–8811. https://doi.org/https://doi.org/10.1128/jvi.77.16.8801-8811.2003
- Burley, S. K., Berman, H. M., Bhikadiya, C., Bi, C., Chen, L., Di Costanzo, L., Christie, C., Dalenberg, K., Duarte, J. M., Dutta, S., Feng, Z., Ghosh, S., Goodsell, D. S., Green, R. K., Guranovic, V., Guzenko, D., Hudson, B. P., Kalro, T., Liang, Y., … Zardecki, C. (2019). RCSB Protein Data Bank: Biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy. Nucleic Acids Res, 47(D1), D464–D474. https://doi.org/https://doi.org/10.1093/nar/gky1004
- Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet, 395(10223), 507–513. https://doi.org/https://doi.org/10.1016/S0140-6736(20)30211-7
- Darden, T., York, D., & Pedersen, L. (1993). Particle Mesh Ewald: An N· log (N) method for Ewald sums in large systems. Chemical Physics, 98(12), 10089–10092. https://doi.org/https://doi.org/10.1063/1.464397
- Das, S., Sarmah, S., Lyndem, S., Singha Roy, A. (2020). An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics, 13, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1763201.
- de Groot, R. J., Baker, S. C., Baric, R. S., Brown, C. S., Drosten, C., Enjuanes, L., Fouchier, R. A. M., Galiano, M., Gorbalenya, A. E., Memish, Z. A., Perlman, S., Poon, L. L. M., Snijder, E. J., Stephens, G. M., Woo, P. C. Y., Zaki, A. M., Zambon, M., & Ziebuhr, J. (2013). Middle East respiratory syndrome coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. Journal of Virology, 87(14), 7790–7792. https://doi.org/https://doi.org/10.1128/JVI.01244-13
- de Wilde, A. H. (2017). Host factors in coronavirus replication, in roles of host gene and non-coding RNA expression in virus infection (pp. 1–42). Springer.
- Elmezayen, A. (2020). Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal of Biomolecular Structure & Dynamics, 26, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1758791.
- Enjuanes, L., Almazán, F., Sola, I., & Zuñiga, S. (2006). Biochemical aspects of coronavirus replication and virus-host interaction. Annual Review of Microbiology, 60, 211–230. https://doi.org/https://doi.org/10.1146/annurev.micro.60.080805.142157
- Graham, R. L., Donaldson, E. F., & Baric, R. S. (2013). A decade after SARS: Strategies for controlling emerging coronaviruses. Nature Reviews Microbiology, 11(12), 836–848. https://doi.org/https://doi.org/10.1038/nrmicro3143
- Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
- Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/https://doi.org/10.1016/0263-7855(96)00018-5
- Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., & Duan, Y. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582, 289–293. https://doi.org/https://doi.org/10.1038/s41586-020-2223-y.
- Joshi, S., Joshi, M., & Degani, M. S. (2020). Tackling SARS-CoV-2: Proposed targets and repurposed drugs. Future Medicinal Chemistry, 12(17), 1579–1601. https://doi.org/https://doi.org/10.4155/fmc-2020-0147
- Kadioglu, O. (2020). Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning.
- Ke, Z., Oton, J., Qu, K., Cortese, M., Zila, V., McKeane, L., Nakane, T., Zivanov, J., Neufeldt, C. J., Cerikan, B. and Lu, J. M. (2020). Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature, 588, 498–502 . https://doi.org/https://doi.org/10.1038/s41586-020-2665-2
- Khan, R. J. (2020). Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics 1–14.
- Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020). The architecture of SARS-CoV-2 transcriptome. Cell, 181(4), 914–921.e10. https://doi.org/https://doi.org/10.1016/j.cell.2020.04.011
- Kim, J.-M., Chung, Y.-S., Jo, H. J., Lee, N.-J., Kim, M. S., Woo, S. H., Park, S., Kim, J. W., Kim, H. M., & Han, M.-G. (2020). Identification of Coronavirus Isolated from a Patient in Korea with COVID-19. Osong Public Health and Research Perspectives, 11(1), 3–7. https://doi.org/https://doi.org/10.24171/j.phrp.2020.11.1.02
- Knapp, B., Frantal, S., Cibena, M., Schreiner, W., & Bauer, P. (2011). Is an intuitive convergence definition of molecular dynamics simulations solely based on the root mean square deviation possible? Journal of Computational Biology : A Journal of Computational Molecular Cell Biology, 18(8), 997–1005. https://doi.org/https://doi.org/10.1089/cmb.2010.0237
- Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., Rollin, P. E., Dowell, S. F., Ling, A.-E., Humphrey, C. D., Shieh, W.-J., Guarner, J., Paddock, C. D., Rota, P., Fields, B., … Anderson, L. J., SARS Working Group. (2003). A novel coronavirus associated with severe acute respiratory syndrome. The New England Journal of Medicine, 348(20), 1953–1966. https://doi.org/https://doi.org/10.1056/NEJMoa030781
- Kumar, Y., Singh, H., & Patel, C. N. (2020). In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Journal of Infection and Public Health, 13(9), 1210–1223. https://doi.org/https://doi.org/10.1016/j.jiph.2020.06.016
- Lam, S., Lombardi, A., & Ouanounou, A. (2020). COVID-19: A review of the proposed pharmacological treatments. European Journal of Pharmacology, 886, 173451. https://doi.org/https://doi.org/10.1016/j.ejphar.2020.173451
- Li, F. (2016). Structure, function, and evolution of coronavirus spike proteins. Annual Review of Virology, 3(1), 237–261. https://doi.org/https://doi.org/10.1146/annurev-virology-110615-042301
- Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., Xing, X., Xiang, N., Wu, Y., Li, C., Chen, Q., Li, D., Liu, T., Zhao, J., Liu, M., … Feng, Z. (2020). Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. The New England Journal of Medicine, 382(13), 1199–1207. https://doi.org/https://doi.org/10.1056/NEJMoa2001316
- Marra, M. A., Jones, S. J. M., Astell, C. R., Holt, R. A., Brooks-Wilson, A., Butterfield, Y. S. N., Khattra, J., Asano, J. K., Barber, S. A., Chan, S. Y., Cloutier, A., Coughlin, S. M., Freeman, D., Girn, N., Griffith, O. L., Leach, S. R., Mayo, M., McDonald, H., Montgomery, S. B., … Roper, R. L. (2003). The genome sequence of the SARS-associated coronavirus. Science (New York, N.Y.), 300(5624), 1399–1404. https://doi.org/https://doi.org/10.1126/science.1085953
- Martin, J., Letellier, G., Marin, A., Taly, J.-F., de Brevern, A. G., & Gibrat, J.-F. (2005). Protein secondary structure assignment revisited: a detailed analysis of different assignment methods. BMC Structural Biology, 5(1), 17 https://doi.org/https://doi.org/10.1186/1472-6807-5-17
- Menachery, V. D., Graham, R. L., & Baric, R. S. (2017). Jumping species-A mechanism for coronavirus persistence and survival. Current Opinion in Virology, 23, 1–7. https://doi.org/https://doi.org/10.1016/j.coviro.2017.01.002
- Moore, W. (2015). Schrodinger. Cambridge University Press.
- Muralidharan, N. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. Journal of Biomolecular Structure and Dynamics, 16, 1-6. https://doi.org/https://doi.org/10.1080/07391102.2020.1752802.
- Pant, S. (2020). Peptide-like and small-molecule inhibitors against covid-19. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1757510
- Paules, C. I., Marston, H. D., & Fauci, A. S. (2020). Coronavirus infections-More than just the common cold. JAMA, 323(8), 707–708. https://doi.org/https://doi.org/10.1001/jama.2020.0757
- Peiris, J. S. M., Lai, S. T., Poon, L. L. M., Guan, Y., Yam, L. Y. C., Lim, W., Nicholls, J., Yee, W. K. S., Yan, W. W., Cheung, M. T., Cheng, V. C. C., Chan, K. H., Tsang, D. N. C., Yung, R. W. H., Ng, T. K., & Yuen, K. Y. (2003). Coronavirus as a possible cause of severe acute respiratory syndrome. The Lancet, 361(9366), 1319–1325. https://doi.org/https://doi.org/10.1016/S0140-6736(03)13077-2
- Perlman, S., & Netland, J. (2009). Coronaviruses post-SARS: Update on replication and pathogenesis. Nature Reviews. Microbiology, 7(6), 439–450. https://doi.org/https://doi.org/10.1038/nrmicro2147
- Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera-A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/https://doi.org/10.1002/jcc.20084
- Prajapat, M., Sarma, P., Shekhar, N., Avti, P., Sinha, S., Kaur, H., Kumar, S., Bhattacharyya, A., Kumar, H., Bansal, S., & Medhi, B. (2020). Drug targets for corona virus: A systematic review. Indian Journal of Pharmacology, 52(1), 56–65. https://doi.org/https://doi.org/10.4103/ijp.IJP_115_20
- Release, S. (2017). 2: LigPrep. Schrödinger, LLC.
- Release, S. (2018). 4: Glide. Schrödinger, LLC.
- Robertson, M. J., Tirado-Rives, J., & Jorgensen, W. L. (2015). Improved peptide and protein torsional energetics with the OPLSAA force field. Journal of Chemical Theory and Computation, 11(7), 3499–3509. https://doi.org/https://doi.org/10.1021/acs.jctc.5b00356
- Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M.-H., Tong, S., Tamin, A., Lowe, L., Frace, M., DeRisi, J. L., Chen, Q., Wang, D., Erdman, D. D., Peret, T. C. T., … Bellini, W. J. (2003). Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (New York, N.Y.), 300(5624), 1394–1399. https://doi.org/https://doi.org/10.1126/science.1085952
- Rout, J., Swain, B. C., Tripathy, U. (2020). In silico investigation of spice molecules as potent inhibitor of SARS-CoV-2. Journal of Biomolecular Structure and Design, 17, 1–15. https://doi.org/https://doi.org/10.1080/07391102.2020.1819879.
- Salman, S., Shah, F. H., Idrees, J., Idrees, F., Velagala, S., Ali, J., & Khan, A. A. (2020). Virtual screening of immunomodulatory medicinal compounds as promising anti-SARS-CoV-2 inhibitors. Future Virology, 15(5), 267–275. https://doi.org/https://doi.org/10.2217/fvl-2020-0079
- Saluja, A. K., & Ganeshpurkar, A. (2016). The pharmacological potential of Rutin. Saudi Pharmaceutical Journal, 25(2), 149–164. https://doi.org/https://doi.org/10.1016/j.jsps.2016.04.025
- Schrödinger, L. (2011). Protein preparation wizard. Epik version, 2, Schrödinger, LLC, New York, NY.
- Tian, W., Chen, C., Lei, X., Zhao, J., & Liang, J. (2018). CASTp 3.0: Computed atlas of surface topography of proteins. Nucleic Acids Research, 46(W1), W363–W367. https://doi.org/https://doi.org/10.1093/nar/gky473
- Wei, T., Wang, H., Wu, X., Lu, Y., Guan, S., Dong, F., & Wang, G. (2020). In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy. Chin J Integr Med, 1, 1–7. https://doi.org/https://doi.org/10.1007/s11655-020-3427-6.
- Ton, A. ‐T., Gentile, F., Hsing, M., Ban, F., & Cherkasov, A. (2020). Rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 1.3 billion compounds. Molecular Informatics, 39(8), 2000028. https://doi.org/https://doi.org/10.1002/minf.202000028
- Ullrich, S., & Nitsche, C. (2020). The SARS-CoV-2 main protease as drug target. Bioorganic & Medicinal Chemistry Letters, 30(17), 127377. https://doi.org/https://doi.org/10.1016/j.bmcl.2020.127377
- Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., Assempour, N., Iynkkaran, I., Liu, Y., Maciejewski, A., Gale, N., Wilson, A., Chin, L., Cummings, R., Le, D., … Wilson, M. (2018). DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Research, 46(D1), D1074–D1082. https://doi.org/https://doi.org/10.1093/nar/gkx1037
- Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., Zheng, M., Chen, L., & Li, H. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B, 10(5), 766–788. https://doi.org/https://doi.org/10.1016/j.apsb.2020.02.008
- Xue, X., Yu, H., Yang, H., Xue, F., Wu, Z., Shen, W., Li, J., Zhou, Z., Ding, Y., Zhao, Q., Zhang, X. C., Liao, M., Bartlam, M., & Rao, Z. (2008). Structures of two coronavirus main proteases: Implications for substrate binding and antiviral drug design. Journal of Virology, 82(5), 2515–2527. https://doi.org/https://doi.org/10.1128/JVI.02114-07
- Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012). Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. The New England Journal of Medicine, 367(19), 1814–1820. https://doi.org/https://doi.org/10.1056/NEJMoa1211721
- Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science (New York, N.Y.), 368(6489), 409–412. https://doi.org/https://doi.org/10.1126/science.abb3405
- Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020). Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery, 6, 14–14. https://doi.org/https://doi.org/10.1038/s41421-020-0153-3
- Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W., China Novel Coronavirus Investigating and Research Team. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/https://doi.org/10.1056/NEJMoa2001017